Cite
HARVARD Citation
Hilton, T. et al. (n.d.). Preliminary analysis of immune responses in patients enrolled in a Phase II trial of Cyclophosphamide with Allogenic DRibble Vaccine Alone (DPV-001) or with GM-CSF or Imiquimod for adjuvant treatment of Stage IIIA or IIIB NSCLC. Journal for immunotherapy of cancer. p. . [Online].